Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +0.57% | +2.33% | -21.78% |
02/05 | Vor Bio Appoints Fouad Namouni to its Board of Directors | CI |
21/03 | Stifel Cuts Price Target on Vor Biopharma to $12 From $15, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.78% | 120M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.39% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Oppenheimer Cuts Vor Biopharma Price Target to $15 From $18, Maintains Outperform Rating